Patrys ASX and media release 06/11/13
It also presents a unique opportunity for Patrys to fast track the development of the PATSM6 product in both the USA and Europe.
http://www.fda.gov/forconsumers/byaudience/forpatientadvocates/speedingaccesstoimportantnewtherapies/ucm128291.htm
Fast Track, Breakthrough Therapy, Accelerated Approval and Priority Review Expediting Availability of New Drugs for Patients with Serious Conditions
Also this might be nice
http://www.fda.gov/forconsumers/consumerupdates/ucm107293.htm
Waiver of Prescription Drug User Fee Act (PDUFA) filing fees (over $1,000,000 per application for FY 2009)
Patrys ASX and media release 06/11/13It also presents a unique...
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.40M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.7¢ | 0.6¢ | $14.17K | 2.087M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 132483 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 1945092 | 5 |
View Market Depth
| Last trade - 15.48pm 29/07/2024 (20 minute delay) ? |
| PAB (ASX) Chart |